Cyclazocine revisited
- 1 November 1996
- journal article
- review article
- Published by Springer Nature in Neurochemical Research
- Vol. 21 (11) , 1369-1373
- https://doi.org/10.1007/bf02532378
Abstract
Recently synthesized compounds which have long-term mu antagonist activity and short-term kappa agonist effects prevent self-administration of cocaine and morphine in rats. Cyclazocine, a compound synthesized in 1962 and studied in animals and man in the 1960's and in the early 1970's is a mu antagonist in rats and man and is a potent kappa agonist in both species. It also prevents self-administration of cocaine and morphine in rats. Although it produces unpleasant side effects in man, subjects become tolerant to these side effects but not to the antagonistic actions of the drug after prolonged administration.Keywords
This publication has 17 references indexed in Scilit:
- Kappa opioid inhibition of morphine and cocaine self-administration in ratsBrain Research, 1995
- U50,488, a κ opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of ratsNeuroscience Letters, 1994
- 14.alpha.,14'.beta.-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis(7,8-dihydromorphinone) and 14.alpha.,14'.beta.-[Dithiobis[(2-oxo-2,1-ethanediyl)imino]]bis-7,8-dihydro-N-(cyclopropyl- methyl)normorphinone: Chemistry and Opioid Binding PropertiesJournal of Medicinal Chemistry, 1994
- Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.1993
- Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.Proceedings of the National Academy of Sciences, 1992
- Buprenorphine Suppresses Cocaine Self-Administration by Rhesus MonkeysScience, 1989
- Role of opioid antagonists in treating intravenous cocaine abuseLife Sciences, 1989
- Cyclazocine treatment of opiate dependence: A progress reportComprehensive Psychiatry, 1971
- An experimental study in the treatment of narcotic addicts with cyclazocineClinical Pharmacology & Therapeutics, 1966
- Studies of the dependence-producing potential of the narcotic antagonist 2-cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (cyclazocine, WIN-20,740, ARC II-c-3).1965